Incite Health Inc. supports Gov. Shapiro’s landmark legislation improving health outcomes for Pennsylvanians at the Pennsylvania Biotechnology Center (PABC)
WHO: Incite Health Inc., a leading CLIA-certified, CAP-accredited high-complexity diagnostic laboratory
WHAT: News conference to commend the Governor and the General Assembly for ensuring greater health equity through wider access to biomarker testing and a special announcement
WHEN: Thursday, July 25, 11 a.m. sharp.
WHERE: PABC, 3805 Old Easton Road, Doylestown, PA 18902
Incite Health, Inc. CEO, Ren Capocasale and his team will be joined by…
- Sen. Steve Santarsiero of Bucks County,
- Rep. Kyle Mullins of Lancaster Co.,
- Chris Molineux, President & CEO of Life Science Pa, (LSPA), and
- Lou Kassa, CEO of the PABC, Hepatitis B Foundation and Blumberg Institute.
Incite Health commends Gov. Josh Shapiro and the General Assembly for signing and passage of House Bill 1754 into law. This new law mandates comprehensive biomarker testing coverage by all state regulated health plans, including Medicaid, ensuring more Pennsylvanian residents can benefit from enhanced precision medicine. Incite Health is leading the way in biomarker testing through its pharmacogenomic and immune system biomarker platforms that are both covered under House Bill 1754.
Sen. Santarsiero will be the keynote speaker. Rep. Mullins, who was prime sponsor of HB1754, also will speak.Incite Health’s CEO Ren Capocasale will announce exciting launch details of the API interface for Incite Health customers and patients for accessing their biomarker data generated through Incite Health’s pharmacogenomic testing (PGx) platform at the conclusion of the event. We invite all area news media to cover this exciting celebration.
For those that cannot send someone, Incite Health will provide photos and a news release with details.
Questions? Please call Ren Capocasale at 856-745-5045 or email him at rcapocasale@incitehealth.com.
